Education
About Us
Working with TipRanks
Follow Us
Rapid Dose Therapeutics Corp (TSE:DOSE)
:DOSE
RESEARCH TOOLSreports
Total Valuation
Rapid Dose Therapeutics Corp has a market cap or net worth of C$26.33M. The enterprise value is C$37.34M.
Market CapC$26.33M
Enterprise ValueC$37.34M
Share Statistics
Rapid Dose Therapeutics Corp has 128,442,080 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding128,442,080
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Rapid Dose Therapeutics Corp’s return on equity (ROE) is 1.36 and return on invested capital (ROIC) is 530.86%.
Return on Equity (ROE)1.36
Return on Assets (ROA)-2.28
Return on Invested Capital (ROIC)530.86%
Return on Capital Employed (ROCE)3.62
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.54
Inventory Turnover3.45
Valuation Ratios
The current PE Ratio of Rapid Dose Therapeutics Corp is -4.27. Rapid Dose Therapeutics Corp’s PEG ratio is -0.38.
PE Ratio-4.27
PS Ratio0.00
PB Ratio-5.82
Price to Fair Value-5.82
Price to FCF-8.00
Price to Operating Cash Flow-8.00
PEG Ratio-0.38
Income Statement
In the last 12 months, Rapid Dose Therapeutics Corp had revenue of 1.02M and earned -4.31M in profits. Earnings per share was -0.04.
Revenue1.02M
Gross Profit563.41K
Operating Income-3.74M
Pretax Income-4.31M
Net Income-4.31M
EBITDA-3.02M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -2.31M and capital expenditures -2.00, giving a free cash flow of -2.31M billion.
Operating Cash Flow-2.31M
Free Cash Flow-2.31M
Free Cash Flow per Share-0.02
Dividends & Yields
Rapid Dose Therapeutics Corp pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.38
52-Week Price Change-9.09%
50-Day Moving Average0.19
200-Day Moving Average0.20
Relative Strength Index (RSI)54.88
Average Volume (3m)18.74K
Important Dates
Rapid Dose Therapeutics Corp upcoming earnings date is Jul 25, 2025, TBA Not Confirmed.
Last Earnings DateJan 29, 2025
Next Earnings DateJul 25, 2025
Ex-Dividend Date―
Financial Position
Rapid Dose Therapeutics Corp as a current ratio of 0.23, with Debt / Equity ratio of -63.60%
Current Ratio0.23
Quick Ratio0.19
Debt to Market Cap0.13
Net Debt to EBITDA-0.76
Interest Coverage Ratio-5.65
Taxes
In the past 12 months, Rapid Dose Therapeutics Corp has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Rapid Dose Therapeutics Corp EV to EBITDA ratio is -6.83, with an EV/FCF ratio of -9.00.
EV to Sales20.25
EV to EBITDA-6.83
EV to Free Cash Flow-9.00
EV to Operating Cash Flow-9.00
Balance Sheet
Rapid Dose Therapeutics Corp has C$40.10K in cash and marketable securities with C$0.00 in debt, giving a net cash position of C$2.57M billion.
Cash & Marketable SecuritiesC$40.10K
Total DebtC$0.00
Net CashC$2.57M
Net Cash Per ShareC$0.02
Tangible Book Value Per Share-C$0.03
Margins
Gross margin is -17.03%, with operating margin of -366.39%, and net profit margin of -422.03%.
Gross Margin-17.03%
Operating Margin-366.39%
Pretax Margin-422.03%
Net Profit Margin-422.03%
EBITDA Margin-296.42%
EBIT Margin-357.21%
Analyst Forecast
The average price target for Rapid Dose Therapeutics Corp is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast53.98%
EPS Growth Forecast-37.86%